- Over 500 cryogenic freezers (-196°C to -150°C)
- More than 1,500 ultra-low (-80°C) temperature freezers
- Delivering precision in cold chain logistics with knowledge in compliance expertise, real-time visibility, and customized shipping solutions
- Good manufacturing practice (GMP) warehousing capacity with more than 15,000 CRT pallet positions
Plus, with the addition of warehouse management system and client portal, customers are able to gain real-time insight into their inventory and the confidence of accurate, on-time retrieval.
“New Jersey is proud to be the home of SciSafe’s latest expansion,” said. New Jersey Gov. Phil Murphy, who attended the ribbon-cutting event, “This new facility is a testament to our state’s role as a global leader in life sciences and innovation. By investing in cutting-edge infrastructure and creating high-quality jobs, SciSafe is helping to strengthen our economy while supporting groundbreaking research that will improve lives here in New Jersey and around the world.”
Fast facts: SciSafe East Brunswick biorepository
Location: East Brunswick, NJ, off the I-95 corridor
Facility size: 5 million+ cubic feet of storage
Freezer capacity: 500+ cryogenic freezers (-196°C to -150°C); 1,500+ ultra-low freezers (-80°C)
GMP Warehousing: 15,000+ CRT pallet positions
Local leaders also praised the expansion’s economic and industry impact.
“We’re thrilled to see SciSafe expand in East Brunswick,” said East Brunswick Mayor Brad Cohen. “This new facility is a tremendous investment in our community, bringing quality jobs and reinforcing our township as a destination for growth in the biotech and health care industries. We look forward to a strong partnership that benefits both residents and the broader region.”
Insights from LogiPharma USA
In other news, the Pharmaceutical Commerce team just returned from LogiPharma USA in Boston, a pharma supply chain conference. Plenty of coverage was gathered during the event, including a session on ways to tackle temperature monitoring in direct-to-patient shipments.2
The session dove into ways to build real-time visibility and control into the last mile; choose the right level of monitoring, including an active, passive, or hybrid model; make sure packaging, technology, and courier services for at-home shipments are all aligned; and alleviate risk in patient settings.
References
1. SciSafe Announces New Facility, Expansion of Cold Chain Capabilities in New Jersey. Massachusetts Biotechnology Council. September 30, 2025. Accessed October 3, 2025. https://www.massbio.org/news/member-news/scisafe-announces-new-facility-expansion-of-cold-chain-capabilities-in-new-jersey/
2. Saraceno N. LogiPharma USA 2025: How Pharma Leaders Are Tackling Temperature Monitoring in Direct-to-Patient Shipments. Pharmaceutical Commerce. October 2, 2025. Accessed October 3, 2025. https://www.pharmaceuticalcommerce.com/view/how-pharma-leaders-tackling-temp-monitoring-direct-to-patient-shipments